BELLOCCHI, MARIA CONCETTA
 Distribuzione geografica
Continente #
NA - Nord America 10.658
EU - Europa 1.166
AS - Asia 793
SA - Sud America 103
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 12.735
Nazione #
US - Stati Uniti d'America 10.645
SG - Singapore 487
IT - Italia 296
DE - Germania 146
UA - Ucraina 117
SE - Svezia 115
IE - Irlanda 111
CN - Cina 109
HK - Hong Kong 106
BR - Brasile 93
RU - Federazione Russa 91
PL - Polonia 71
FR - Francia 67
GB - Regno Unito 47
FI - Finlandia 43
KR - Corea 35
BE - Belgio 17
NL - Olanda 15
CZ - Repubblica Ceca 14
ID - Indonesia 14
AT - Austria 10
CA - Canada 7
IN - India 7
JP - Giappone 5
MX - Messico 5
UZ - Uzbekistan 5
VN - Vietnam 5
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
TR - Turchia 3
BD - Bangladesh 2
CM - Camerun 2
EU - Europa 2
MN - Mongolia 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NP - Nepal 1
PA - Panama 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
ZW - Zimbabwe 1
Totale 12.735
Città #
Woodbridge 2.879
Wilmington 2.720
Houston 2.437
Fairfield 413
Singapore 324
Chandler 277
Ann Arbor 232
Ashburn 184
Seattle 175
Rome 167
Cambridge 136
Hong Kong 106
Dublin 103
Jacksonville 98
Santa Clara 88
Medford 82
New York 70
Creede 69
Kraków 69
The Dalles 53
Beijing 52
Dearborn 45
Lawrence 37
San Diego 26
Milan 25
Colorado Springs 22
Nuremberg 19
Council Bluffs 18
Moscow 18
Mülheim 18
Brussels 17
Munich 17
Helsinki 16
Zhengzhou 15
Jakarta 12
Menlo Park 12
Mountain View 12
Redwood City 10
Brno 9
Florence 9
London 9
Guangzhou 8
São Paulo 8
Boardman 7
Falls Church 7
Magenta 7
Palo Alto 6
Seoul 6
Cedarhurst 5
Dong Ket 5
Los Angeles 5
Norwalk 5
Olomouc 5
University Park 5
Binasco 4
Cagliari 4
Kunming 4
Phoenix 4
Saint Petersburg 4
San Mateo 4
Verona 4
Vienna 4
Bologna 3
Chiswick 3
Detroit 3
Fuzhou 3
Hounslow 3
La Veta 3
Mumbai 3
North Bergen 3
North Hollywood 3
Padova 3
Tashkent 3
Toronto 3
Acton 2
Albano Laziale 2
Amsterdam 2
Ancona 2
Angra dos Reis 2
Bagnoregio 2
Belo Horizonte 2
Bogotá 2
Camaçari 2
Changsha 2
Engelhard 2
Fortaleza 2
Franca 2
Hefei 2
Jinan 2
João Pessoa 2
Kyiv 2
Lappeenranta 2
Lima 2
Manila 2
Milazzo 2
Montréal 2
Nanchang 2
Nanjing 2
Nepi 2
Paris 2
Totale 11.299
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 520
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 480
Virologic correlates of adherence to antiretroviral medications and therapeutic failure 467
Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso 456
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 450
MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases 445
Macrophages and HIV infection: Therapeutical approaches toward this strategic virus reservoir 443
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 438
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors 430
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 429
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 426
Population variation analysis at nine loci containing expressed trinucleotide repeats 422
Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso 421
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy 407
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy 399
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme 397
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure 395
Incomplete APOBEC3G/F neutralization by HIV-1 Vif mutants facilitates the genetic evolution from CCR5 to CXCR4 usage 395
Dynamics of NRTI resistance mutations during therapy interruption 388
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients with Acute Hepatitis B 382
Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors 375
Temporal change in the use of genotypic resistance testing over the years 1999--2003 373
Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir 371
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children 352
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy 349
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 346
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 270
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 193
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 179
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 161
Establishment of a Seronegative Occult Infection With an Active Hepatitis B Virus Reservoir Enriched of Vaccine Escape Mutations in a Vaccinated Infant After Liver Transplantation 126
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 104
HHV-8 genetic diversification and its impact on severe clinical presentation of associated diseases 75
Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study 70
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 69
Characterization of HBV and HCV minority quasispecies by ultra-deep pyrosequencing analysis: impact on pathogenicity and response to antiviral drugs 68
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 67
SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021 60
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. 56
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 52
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 47
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects 47
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario? 46
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies 42
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 41
Genetic heterogenicity of HIV-1 protease in drug-naive and drug-treated HIV-positive patients 41
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 40
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 33
Factors predictive of multinucleoside analogue-resistance mutations in an unselected cohort of HAART-failed patients. 32
Factors predictive of virological response after genotyping resistance test (GRT): data from an unselected cohort 32
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 32
The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy 29
Identification of the Minimal Conserved Structure of the HIV-Reverse Transcriptase under the Presence and Absence of Drug Pressure 25
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy 25
Cross-resistance among NNRTIs: evaluation of the option of recycling Efavirenz after Nevirapine failure 24
Using a database of genotype resistance tests to describe characteristics related to detection of the multinucleoside resistance-associated Q151M mutation. 23
Temporal characterization of frequency of drug-resistance associated mutations in the HIV-1 protease and reverse transcriptase 23
First National Prevalence in Italian Horse Population and Phylogenesis Highlight a Fourth Sub-Type Candidate of Equine Hepacivirus 22
Long-term evaluation of the effect of genotype-based antiretroviral therapy upon virological, immunological, and clinical parameters 21
Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors 21
Time to detection and loss of M184 genotypic mutation among HIV patients treated with 3TC and failing an HAART regimen 19
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation 18
Totale 12.989
Categoria #
all - tutte 32.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.581


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020700 0 0 0 0 0 0 0 0 0 284 199 217
2020/20211.996 217 240 235 234 203 207 268 183 39 69 69 32
2021/2022570 42 45 33 36 20 35 26 25 123 45 24 116
2022/2023895 77 66 52 88 47 131 38 224 51 69 41 11
2023/2024323 55 5 27 16 30 85 7 11 12 18 3 54
2024/20251.314 67 351 171 134 41 76 170 76 157 71 0 0
Totale 12.989